Clinical Trials Logo

Pain, Postoperative clinical trials

View clinical trials related to Pain, Postoperative.

Filter by:

NCT ID: NCT04838028 Completed - Chronic Pain Clinical Trials

Chronic Postoperative Pain After Laparoscopic Groin Hernia Repair

Start date: September 1, 2012
Phase:
Study type: Observational

The study attempts to quantify the relative risks for chronic postoperative inguinal pain (CPIP) depending on different combinations of mesh and mesh fixation. For this purpose the investigators will analyze data from the Swedish Hernia Registry (SHR).

NCT ID: NCT04837170 Not yet recruiting - Postoperative Pain Clinical Trials

Safety and Efficacy Evaluation of S (+) - Ketamine in Adults

Start date: May 1, 2021
Phase: Phase 4
Study type: Interventional

A multicenter, randomized, open-label, active controlled pragmatic clinical trial that evaluates the safety and efficacy of S (+) -ketamine for postoperative acute pain in adults in perioperative settings.

NCT ID: NCT04837014 Recruiting - Pain, Postoperative Clinical Trials

Eliminating Narcotic Prescriptions From Outpatient Minimally Invasive Gynecologic Surgery

eNARCOS
Start date: July 4, 2022
Phase: N/A
Study type: Interventional

Laparoscopic gynecologic surgeries are generally very well tolerated procedures, and patients are able to go home on the same day, with a prescription for pain control. There is currently a very wide range of prescription practice within the gynecology community in regards to opioids following surgery, and patients are going home with anything from zero to 5 or even 20 tabs of narcotics. Aside from negative side effect of opioids (like nausea/vomiting, dizziness, constipation, and possibly addiction), unnecessary opioid prescriptions and excess unused narcotics is one of the major contributors to narcotic abuse in the community, worsening an ongoing nationwide opioid crisis. Although most patients report low pain level following these kinds of procedure, there are no current standard prescriptions after gynecologic laparoscopy. In an effort to standardize discharge prescriptions following gynecologic laparoscopy, this study aims to find an optimal regimen for pain control in the post-operative period following laparoscopic gynecologic surgery. There will be 2 standardized set of discharge prescriptions to which patient will be randomized; both containing multimodal medications for pain control. Pain control, and patients satisfaction will be measured in the first post-operative week.

NCT ID: NCT04836169 Not yet recruiting - Pain, Postoperative Clinical Trials

Phase 1: Randomized Evaluation of a System to Deliver Mobile Cognitive Behavioral Therapy

P1RESPECT
Start date: October 2021
Phase: N/A
Study type: Interventional

The clinical study described in this Clinical Investigation Plan (CIP) will be completed in two stages, Phase I and Phase II. The results of Phase I will confirm patient use of InCaveo's EOA system with integrated mobile CBT but without tapering to improve The Pain Catastrophizing Scale (PCS) scores, and secondarily scores on the VNS pain scale, the Tampa Scale of Kinesiophobia (TSK), and patient satisfaction scores in the subacute period (defined as 2 weeks to 3 months post TKR). Statistically significant positive results on the Pain Catastrophizing Scale (PCS) will trigger phase 2. Phase 1 will also inform the detailed conditions and patient management algorithms for Phase II.

NCT ID: NCT04835116 Completed - Pain Clinical Trials

Comparison of Post-Operative Analgesia After Percutaneous Nephrolithotomy.

Start date: April 11, 2019
Phase: Phase 4
Study type: Interventional

The rationale of this study was to compare the efficacy of peri-tract bupivacaine infiltration with intravenous post-operative analgesia following PCNL in reference to the context with the previous studies so that we can adopt the better technique to curtail the post-operative pain.

NCT ID: NCT04834440 Not yet recruiting - Postoperative Pain Clinical Trials

Ropivacaine Use in Femoral Nerve Block; What is the Minimal Effective Analgesic Concentration (MEAC 90)

Start date: May 1, 2021
Phase: Phase 4
Study type: Interventional

The aim of this study is to determine the minimal effective ropivacaine concentration required to provide adequate analgesic femoral nerve block in 90% of patients (MEAC90)

NCT ID: NCT04833296 Not yet recruiting - Postoperative Pain Clinical Trials

Ropivacaine Use in Interscalene Block; What is the Minimal Effective Analgesic Concentration (MEAC 90)

Start date: May 1, 2021
Phase: Phase 4
Study type: Interventional

This study aim to calculate the minimal effective ropivacaine concentration required achieve successful analgesic interscalene block in 90% of patients (MEAC90)

NCT ID: NCT04831736 Completed - Postoperative Pain Clinical Trials

Effect of Postoperative Single Dose of Ketamine on Pain After Mastectomy

Start date: April 26, 2021
Phase: Phase 4
Study type: Interventional

This is a randomized, single blinded, placebo-controlled trial to study the effectiveness of a subanesthetic dose (0.6mg/kg) of ketamine versus placebo (saline) on postoperative pain on adult women undergoing mastectomy. The objective of the study is to examine the effect of a subanesthetic dose (0.6mg/kg) of ketamine vs. saline control on postoperative pain in subjects who have undergone mastectomy.

NCT ID: NCT04828980 Completed - Anxiety Clinical Trials

Utilization of Different Virtual Reality Experiences

Start date: February 1, 2021
Phase: N/A
Study type: Interventional

This trial studies differences between a mindfulness and a gaming virtual reality (VR) experience as a means for preoperative anxiety management and postoperative pain management among patients after head and neck surgery. Investigators will assess differences in anxiety scores, pain scores, physiologic measures, and subjective patient experiences.

NCT ID: NCT04828109 Completed - Surgery Clinical Trials

Digital Intervention Postoperative Protocol

Start date: October 25, 2021
Phase: N/A
Study type: Interventional

Postoperative recovery after head and neck surgery is complex, and often requires utilization of narcotic medications. The aim of this study is to evaluate reduction in pain and use of opioid medications through Virtual Reality (VR) and Fitbit wearable activity devices.